IDT Australia Investor Highlights 2020
Filed with ASX · · 1 page · English
Earlier from IDT Australia
- Appendix 4E
- Cann Group Executes New Export Supply Agreements
- Business Update - COVID-19
- Medicinal Cannabis GMP manufacturing update
- Half Year Results Presentation
Later from IDT Australia
- Half Yearly Report and Accounts
- IDT Australia FY21 Interim Results and Investor Update
- COVID19 Vaccine Feasibility Assessment
- COVID-19 Vaccine Manufacture discussions with VicGov & MIPS
- Response to ASX Price Query
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia